XP Chemistries AB (XPC) - Net Assets
Based on the latest financial reports, XP Chemistries AB (XPC) has net assets worth Skr39.57 Million SEK (≈ $4.26 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr40.66 Million ≈ $4.38 Million USD) and total liabilities (Skr1.09 Million ≈ $117.34K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read total liabilities of XP Chemistries AB for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr39.57 Million |
| % of Total Assets | 97.32% |
| Annual Growth Rate | 236.31% |
| 5-Year Change | 371.63% |
| 10-Year Change | N/A |
| Growth Volatility | 3570.46 |
XP Chemistries AB - Net Assets Trend (2019–2024)
This chart illustrates how XP Chemistries AB's net assets have evolved over time, based on quarterly financial data. Also explore XP Chemistries AB balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for XP Chemistries AB (2019–2024)
The table below shows the annual net assets of XP Chemistries AB from 2019 to 2024. For live valuation and market cap data, see XPC stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr21.56 Million ≈ $2.32 Million |
-16.05% |
| 2023-12-31 | Skr25.69 Million ≈ $2.76 Million |
-11.63% |
| 2022-12-31 | Skr29.07 Million ≈ $3.13 Million |
-7.13% |
| 2021-12-31 | Skr31.30 Million ≈ $3.37 Million |
+584.56% |
| 2020-12-31 | Skr4.57 Million ≈ $492.07K |
+9044.90% |
| 2019-12-31 | Skr50.00K ≈ $5.38K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to XP Chemistries AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2574687800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr4.86 Million | 22.53% |
| Other Components | Skr42.45 Million | 196.86% |
| Total Equity | Skr21.56 Million | 100.00% |
XP Chemistries AB Competitors by Market Cap
The table below lists competitors of XP Chemistries AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BELLUSCURA PLC LS -01
F:9VQ
|
$3.55 Million |
|
XORTX Therapeutics Inc
V:XRTX
|
$3.55 Million |
|
TwentyFour Select Monthly Income Fund Ltd
LSE:SMIF
|
$3.55 Million |
|
Saferoads Holdings Ltd
AU:SRH
|
$3.56 Million |
|
STL Global Limited
NSE:SGL
|
$3.54 Million |
|
PROSPECT RIDGE RESOURCES
F:0ED
|
$3.53 Million |
|
Identitii Ltd
AU:ID8
|
$3.53 Million |
|
AIOS Tech Inc.
NASDAQ:AIOS
|
$3.53 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in XP Chemistries AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 25,687,897 to 21,564,945, a change of -4,122,952 (-16.1%).
- Net loss of 7,133,622 reduced equity.
- New share issuances of 2,846,744 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-7.13 Million | -33.08% |
| Share Issuances | Skr2.85 Million | +13.2% |
| Other Changes | Skr163.93K | +0.76% |
| Total Change | Skr- | -16.05% |
Book Value vs Market Value Analysis
This analysis compares XP Chemistries AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.81x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 51.75x to 0.81x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | Skr0.00 | Skr0.17 | x |
| 2020-12-31 | Skr0.29 | Skr0.17 | x |
| 2021-12-31 | Skr2.04 | Skr0.17 | x |
| 2022-12-31 | Skr0.94 | Skr0.17 | x |
| 2023-12-31 | Skr0.82 | Skr0.17 | x |
| 2024-12-31 | Skr0.20 | Skr0.17 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently XP Chemistries AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -33.08%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2512.39%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.05x
- Recent ROE (-33.08%) is below the historical average (-30.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -47.22% | -5806.11% | 0.01x | 1.14x | Skr-2.62 Million |
| 2021 | -14.52% | -1626.81% | 0.01x | 1.10x | Skr-7.68 Million |
| 2022 | -27.23% | -749.81% | 0.03x | 1.05x | Skr-10.82 Million |
| 2023 | -31.29% | -1211.26% | 0.02x | 1.06x | Skr-10.61 Million |
| 2024 | -33.08% | -2512.39% | 0.01x | 1.05x | Skr-9.29 Million |
Industry Comparison
This section compares XP Chemistries AB's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $76,555,000
- Average return on equity (ROE) among peers: -11.93%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| XP Chemistries AB (XPC) | Skr39.57 Million | -47.22% | 0.03x | $3.54 Million |
| Serstech AB (SERT) | $76.56 Million | -11.93% | 0.24x | $15.33 Million |
About XP Chemistries AB
XP Chemistries AB (publ), a biotechnology company, engages in the development and production of forest-based capsaicin and analogues. It offers animal feed ingredients; personal care and cosmetic ingredients; pure capsaicinoids; and self-defense spray ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.